However, the KLF5 promoter has been found to be hyper-methylated in BCR-ABL1 expressing B-ALL [19], suggesting that KLF5 transcriptional regulation may be relevant and as such it may act as a tumor suppressor in this specific type of leukemia. The gene discussed is KLF5; the disease is leukemia.